Abstract
In the past few years concerns have been expressed by clinical investigators regarding the variable and unpredictable risk of both hemorrhage and thrombosis in patients receiving heparin. Recent observations tend to indicate that a number of elements may contribute to variability in response to heparin. Possible factors which may be responsible include differences in chemical composition and in methods of assay, variable absorption, different types and degrees of alteration in coagulation mechanism of patients, and inaccuracies or inadequacies in methods for monitoring therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
